‘Pharma Bro’ was on ‘war path’ after firm tried to force him out: CEO

The current CEO of Martin Shkreli’s drug company Retrophin testified Friday that the “Pharma Bro” went on a “war path” to hurt the company in retaliation to being forced out. Shkreli’s reign as CEO of the biopharmaceutical firm was chaotic – and included antics of out-of-control tweeting, inappropriately communicating with investors and even hiring a…

Full Story Via Business | New York Post

Comments are closed.